Xcout Intel
Halia Therapeutics, Inc.
Halia Therapeutics, Inc. is a clinical-stage biotechnology research company focused on discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and other diseases. The company is actively advancing global clinical programs and is headquartered in Lehi, Utah.
Subscribe to see Halia Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Halia Therapeutics, Inc. at a glance
Halia Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $27.4M across the 5 funding rounds on record. Its most recent funding round raised $3.5M in August 2026. Xcout tracks 19 named people at Halia Therapeutics, Inc., including David J. Bearss (Chief Executive Officer).
Halia Therapeutics, Inc. leadership
- David J. BearssChief Executive Officer
- Jeff BurtonChief Financial Officer
- Jeffrey BurtonChief Financial Officer
- Han MyintChief Medical Officer
- David J. BearssCEO and Co-Founder
- Jared BearssChief Operating Officer
13 more named people on record for Halia Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Halia Therapeutics, Inc. funding rounds
At least $27.4M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3.5M | — | |
| SEC Form D filing | $336,833 | — | |
| SEC Form D filing | $12.2M | — | |
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $6.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Halia Therapeutics, Inc. competitors
A few of Halia Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Areteia Therapeutics, Inc. is a clinical-stage biotechnology company located in Foxboro, Massachusetts and Chapel Hill, North Carolina, focused on developing novel inflammation therapies.
Viela Bio, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to the discovery, development, and commercialization of novel therapies for autoimmune and severe inflammatory diseases.
ReAlta Life Sciences, Inc. is a mid-stage clinical biotech company headquartered in Norfolk, Virginia, dedicated to developing novel treatments for severe inflammatory and rare diseases.
Expedition Therapeutics is a clinical-stage biotechnology company headquartered in San Francisco, California, developing novel oral small molecule therapies for serious inflammatory and respiratory diseases.
PhotoPharmics, Inc. is a clinical-stage medical device and pharmaceutical company located in Lehi and American Fork, Utah, focused on evaluating treatments through randomized clinical trials.
Get Halia Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Halia Therapeutics, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Halia Therapeutics, Inc. in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access